KAREN ANTLER: Open Payments
NPI 1083154520 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 13 payments from 7 companies in 2025. Trend: 2023 $514 · 2024 $953 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| PFIZER INC. | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| HEARTFLOW, INC. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
Products named: JARDIANCE, LOKELMA, ELIQUIS, AMVUTTRA, Attruby, FFRct, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, WAINUA.
Industry payments across NY — which companies pay providers there.
